RTP DesportoBorges admite falta de consistência do Sporting mas está "otimista"ESPN DeportesPhillies reclama de waivers a mexicano UrquidyThe Jerusalem PostJewish radio host says he 'charmed' JD Vance after previous criticism for wavering Israel supportESPNDC Belichick resigns as UNC investigation finds disregard for conductDaily MaverickConsistency proved key in Sinesipho Dambile’s remarkable yearInquirerGatchalian flags P295-M fees paid due to transport project delaysוואלהבית המשפט קיבל את עתירת אגם צרפי ומתח ביקורת על שב"סComplete SportsArteta Provides Fitness Update On White, Timber, Mosquera Ahead Brighton vs ArsenalIl Fatto Quotidiano“A 13 anni ero costretta a letto da delle operazioni per una grave forma di scoliosi, ero sempre ferma, ingessata. Ho vissuto l’adolescenza a brandelli”: così Valeria GolinoConsequenceAirPods 5 Are Officially Available: Save $5 on Amazon Right NowNOS SportIn België gaat Van Bommel lastige vragen over Courtois en zoon Ruben niet uit de wegFootball ItaliaOpenda: Juventus move ‘not a mistake’, Vlahovic ‘kept the ball to himself’
The Daily Newsstand · Free, Always
Friday, September 18, 2026

Thailand makes weight-loss pens prescription-only to counter glut of illegal medicines

Translate

Thailand has moved to make weight-loss pens prescription-only, as a glut of the GLP-1 medicines – which mimic the hormones released once someone is full – floods the black market and influencers swarm TikTok to extol the quick wins of the simple injections.

The Southeast Asian nation, which is never far behind wellness or aesthetic trends and has a notorious black market in counterfeit drugs, has seen the uptake of GLP-1 medicines skyrocket, doctors say, including the market-leading Ozempic brand.

But doctors have warned that the US$240 to US$360 monthly cost of having the drugs prescribed by doctors has caused a black market to mushroom, including a tsunami of fake and potentially dangerous smuggled medicines.

View the original on South China Morning Post

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.